Koa Shoji Holdings Co.,Ltd. (TYO:9273)
838.00
-12.00 (-1.41%)
Jan 21, 2026, 3:30 PM JST
Koa Shoji Holdings Revenue
Koa Shoji Holdings had revenue of 5.95B JPY in the quarter ending September 30, 2025, with 18.37% growth. This brings the company's revenue in the last twelve months to 24.19B, up 13.38% year-over-year. In the fiscal year ending June 30, 2025, Koa Shoji Holdings had annual revenue of 23.27B with 5.13% growth.
Revenue (ttm)
24.19B
Revenue Growth
+13.38%
P/S Ratio
1.48
Revenue / Employee
79.58M
Employees
304
Market Cap
35.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 23.27B | 1.14B | 5.13% |
| Jun 30, 2024 | 22.13B | 82.00M | 0.37% |
| Jun 30, 2023 | 22.05B | 1.70B | 8.35% |
| Jun 30, 2022 | 20.35B | 2.54B | 14.24% |
| Jun 30, 2021 | 17.82B | 1.78B | 11.11% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KYORIN Pharmaceutical | 133.68B |
| Mochida Pharmaceutical | 109.05B |
| Zeria Pharmaceutical | 84.85B |
| ASKA Pharmaceutical Holdings | 67.02B |
| Pharma Foods International | 66.38B |
| Fuso Pharmaceutical Industries,Ltd. | 62.05B |
| Fuji Pharma | 51.68B |
| Daito Pharmaceutical | 51.20B |